<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2270">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04616287</url>
  </required_header>
  <id_info>
    <org_study_id>7942</org_study_id>
    <nct_id>NCT04616287</nct_id>
  </id_info>
  <brief_title>Self and Autobiographical Memory in Dementia With Lewy Bodies and Alzheimer Disease: a Behavioral and Multimodal Neuroimaging Study</brief_title>
  <acronym>SELF-MCL</acronym>
  <official_title>Self in Dementia With Lewy Bodies: a Behavioral and Multimodal Neuroimaging Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present project aims at exploring different components of Self-consciousness or 'the&#xD;
      Self', such as autobiographical memory, self-concept and subjective sense of Self, in&#xD;
      dementia with Lewy Bodies (DLB) compared to Alzheimer's disease and to normal ageing.&#xD;
      Anatomical substrates will be studied in multimodal imaging, in terms of volume, anatomical&#xD;
      and functional connectivity. We expect to find an alteration of the different components of&#xD;
      the Self, consecutive to insular dysfunction, a key region within cerebral networks of&#xD;
      self-consciousness, which is damaged early in the course of the disease.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 25, 2021</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">October 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neuropsychological assessment</measure>
    <time_frame>months 3</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Multimodal brain MRI</measure>
    <time_frame>months 3</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Dementia With Lewy Bodies</condition>
  <condition>Alzheimer Disease</condition>
  <condition>Self</condition>
  <condition>Autobiographical Memory</condition>
  <condition>Insular Cortex</condition>
  <arm_group>
    <arm_group_label>dementia with Lewy bodies</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Alzheimer disease</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy elderly subjects</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neuropsychological assessment and Multimodal brain MRI</intervention_name>
    <description>Neuropsychological assessment and Multimodal brain MRI</description>
    <arm_group_label>Alzheimer disease</arm_group_label>
    <arm_group_label>dementia with Lewy bodies</arm_group_label>
    <arm_group_label>healthy elderly subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Inclusion criteria for all participants:&#xD;
&#xD;
          -  Male or female aged between 60 to 80, at the inclusion visit&#xD;
&#xD;
          -  Right-handed&#xD;
&#xD;
          -  Must be affiliated to a social health insurance protection scheme&#xD;
&#xD;
          -  Must be able both to understand the objectives and risks related to the study and to&#xD;
             give a dated and signed informed consent&#xD;
&#xD;
          -  Fluency in French&#xD;
&#xD;
          -  At least 9 years of formal education&#xD;
&#xD;
        Inclusion criteria for group of dementia with Lewy bodies:&#xD;
&#xD;
          -  Subject meeting McKeith et al. criteria (2017)&#xD;
&#xD;
          -  Subject with prodromal dementia with Lewy bodies meeting the DSM-V Mild Cognitive&#xD;
             Impairment criteria (2013)&#xD;
&#xD;
          -  Subject with prodromal or mild dementia with Lewy bodies with an ≤ 20 MMSE score&#xD;
&#xD;
          -  Availability of a caregiver for the inclusion visit&#xD;
&#xD;
        Inclusion criteria for group of Alzheimer disease:&#xD;
&#xD;
          -  Subject meeting Dubois et al. criteria (2014)&#xD;
&#xD;
          -  Subject with prodromal or mild Alzheimer disease with an ≤ 20 MMSE score&#xD;
&#xD;
          -  Availability of a caregiver for the inclusion visit&#xD;
&#xD;
        Inclusion criteria for healthy elderly:&#xD;
&#xD;
          -  Subject must be matched with patients in terms of age, gender and educational level&#xD;
&#xD;
          -  Absence of any cognitive complaint&#xD;
&#xD;
          -  Autonomy must be preserved&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Subjects with significant neuropsychiatric comorbidities&#xD;
&#xD;
          -  Abnormal neurological examination&#xD;
&#xD;
          -  Sensory impairment that may significantly interfere with testing&#xD;
&#xD;
          -  Contraindication to MRI&#xD;
&#xD;
          -  Claustrophobia&#xD;
&#xD;
          -  Heavy psychotropic drug treatment&#xD;
&#xD;
          -  Excessive and regular consumption of alcohol&#xD;
&#xD;
          -  Subject in period of exclusion (determined by a previous or ongoing study)&#xD;
&#xD;
          -  Inability to give the subject informed information&#xD;
&#xD;
          -  Subject under judicial protection&#xD;
&#xD;
          -  Subject under tutorship or guardianship&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nathalie PHILIPPI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nathalie PHILIPPI, MD</last_name>
    <phone>03 88 12 86 31</phone>
    <phone_ext>0033</phone_ext>
    <email>nathalie.philippi@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie PHILIPPI, MD</last_name>
      <phone>03 88 12 86 31</phone>
      <phone_ext>0033</phone_ext>
      <email>nathalie.philippi@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2022</verification_date>
  <study_first_submitted>November 2, 2020</study_first_submitted>
  <study_first_submitted_qc>November 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2020</study_first_posted>
  <last_update_submitted>July 7, 2022</last_update_submitted>
  <last_update_submitted_qc>July 7, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Lewy Body Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

